Stock·NASDAQ·Technology
Marvell Technology Inc. (MRVL)
- Market cap
- $216.80B
- P/E
- 88.37
- Dividend yield
- 0.11%
- Street target
- $350.00median of 46 analysts
- 52-week range
- $70.69 $329.88
The short version
Where MRVL stands today, in four lines, and what CleaRank Financial AI makes of it.
MRVL at a glance
Marvell Technology Inc. (MRVL): Buy, 78/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($175.86 and $241.04).
- Earnings MRVL beat estimates in 7 of its last 8 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $48.7M and bought $2.1M over the last 18 months.
- Valuation P/E of 88.4 against 35.1 for the Technology sector: a premium to peers (+152%).
Figures as of October 16, 2026.
CleaRank Financial AI
Only on CleaRank
Figures we compute ourselves from MRVL's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $227.77 is 5.5% below the 50-day simple moving average of $241.04.Price above its 200-day average ›
The price is 29.5% above the 200-day simple moving average of $175.86.50-day average above the 200-day ›
The 50-day average ($241.04) is 37.1% above the 200-day average ($175.86), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 61% of its 52-week range, between $70.69 and $329.88.
MRVL share price
Pick a period: each tab shows how far MRVL has moved over it, to the last close.
Today's trading
Where MRVL sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 88.37 is 151.8% above the Technology median of 35.1.P/S below the sector median ›
The price-to-sales ratio of 22.94 is 201.9% above the sector median of 7.6.Profitable over the last 12 months ›
Net income over the last 12 months was $2.6B on revenue of $9.5B, a net margin of 27.9%.Beat estimates in most recent reports ›
MRVL beat the EPS estimate in 7 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 0.11%, or $0.24 a share a year.
Key statistics
The headline figures for MRVL.
As of October 16, 2026, MRVL trades at $227.77, with a market value of $216.80B, a P/E ratio of 88.37 and a dividend yield of 0.11%.
What the numbers say
CleaRank Financial AI's reading of MRVL's valuation, growth and risks.
Marvell Technology Inc. (MRVL) demonstrates strong growth with a reported revenue growth of 36.5%, significantly exceeding the Technology sector median of 24.2%.
Its profit margin of 27.93% and return on equity of 16.52% are strong, outperforming sector averages. However, the company's P/E ratio of 88.37 is substantially higher than the sector median of 35.1, suggesting a premium valuation. The price-to-sales ratio of 22.94 also indicates a higher valuation compared to the sector's 7.6. The debt-to-equity ratio of 0.29 is in line with the sector average, indicating a manageable debt load. While valuation metrics appear stretched, the company's superior growth rates and profitability may justify the premium.
MRVL against the Technology sector
How MRVL compares with the median Technology stock CleaRank tracks.
Price to earnings vs sector: MRVL trades at a significant premium to sector peers (+152%), suggesting market expectations for superior growth or market position.
Return vs XLK: Since May 6, 2025, MRVL has gained 272.1% against a gain of 73.7% for XLK.
Performance against XLK
MRVL and the Technology sector fund over the same days.
Revenue and earnings
How much MRVL sells, and how much of it becomes profit.
Revenue growth: Revenue grew 42.1% in FY2026 to $8.2B, from $5.8B a year earlier.
Profit margin: The net margin was 32.6% in FY2026, up from -15.3% the year before.
Profitable: MRVL earned $2.7B in FY2026.
Earnings reality check
Did MRVL beat what analysts expected, and how did the stock react?
Earnings record: MRVL beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 3 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 27, 2026after close | $0.93 | $0.94 | +1.08% | -10.28% | -13.51% |
| May 27, 2026after close | $0.79 | $0.80 | +1.27% | +3.09% | +51.81% |
| Mar 5, 2026after close | $0.79 | $0.80 | +1.27% | +18.35% | +15.84% |
| Dec 2, 2025after close | $0.74 | $0.76 | +2.70% | +7.87% | -4.30% |
| Aug 28, 2025after close | $0.67 | $0.67 | +0.00% | -18.59% | -18.00% |
| May 29, 2025after close | $0.61 | $0.62 | +1.64% | -5.55% | +2.24% |
| Mar 5, 2025after close | $0.59 | $0.60 | +1.69% | -19.81% | -22.51% |
| Dec 3, 2024after close | $0.41 | $0.43 | +4.88% | +23.19% | +11.23% |
As of October 16, 2026, MRVL has beaten the analyst EPS estimate in 7 of its last 8 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on August 27, 2026, came in 1.08% above the estimate and the stock moved -10.28% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/3RSI not overbought or oversold ›
The 14-day RSI is 37.5, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 37.5 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank AI analysis of MRVL
The score, the reasoning behind it, and what could move the price next.
Marvell Technology Inc. (MRVL) exhibits bearish momentum on its 14-day RSI, which stands at 37.51, indicating a potential for further downside or consolidation.
The stock is currently trading below its 50-day SMA of $241.04 and its 20-day EMA of $255.91, suggesting short-term headwinds. However, it remains above its 200-day SMA of $175.86, which acts as a key support level. The MACD indicator shows a positive value of 2.55, but its proximity to zero suggests a neutral trend. Key support is seen at the 200-day SMA, while resistance levels are indicated by the 50-day SMA and the 20-day EMA.
Strong Revenue Growth Projections ›
Analysts forecast revenue growth of 47.00% for the current year and 63.00% for next year, driven by demand in data centers, automotive, and 5G infrastructure.
Source: Wall Street EstimatesAnalyst Price Target Upside ›
The median analyst price target of $350 implies a 53.7% upside potential from the current stock price of $227.77.
Source: Wall Street Estimates
Moderate Insider Selling Signal ›
Insiders have sold $48.7 million worth of stock versus purchases of $2.1 million, indicating a 'Moderate Sell Signal' that warrants monitoring.
Source: Insider TransactionsTrading Below Short-Term Moving Averages ›
The stock is currently trading below its 50-day SMA ($241.04) and 20-day EMA ($255.91), suggesting short-term technical weakness.
Source: Technical Analysis
- Given the stock's current position below its 50-day and 20-day moving averages, consider waiting for a technical confirmation of a trend reversal before initiating new long positions.
Technical indicators
Momentum and trend for MRVL, from its daily closes.
As of October 16, 2026, with MRVL at $227.77, its 14-day RSI is 37.5 (showing bearish momentum without being oversold), its 50-day simple moving average is $241.04 and its 200-day is $175.86.
Calculated by CleaRank on daily closes as of October 16, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What MRVL moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 16, 2026, MRVL's 1-year correlation of daily returns is +0.58 with S&P 500 (SPY), +0.68 with Nasdaq 100 (QQQ), +0.21 with Bitcoin (BTC) and +0.16 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
42 of 46 analysts rate it a buy or strong buy, 4 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $350.00 is 53.7% above the price.More buy ratings than three months ago ›
42 of 46 rate it a buy now, against 38 of 43 three months ago.
MRVL Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 7, 2026 | UBS | Maintains | Buy |
| Oct 7, 2026 | Jefferies | Maintains | Buy |
| Oct 7, 2026 | JP Morgan | Maintains | Overweight |
| Oct 7, 2026 | Wells Fargo | Maintains | Overweight |
| Oct 7, 2026 | Wolfe Research | Maintains | Outperform |
| Oct 7, 2026 | Morgan Stanley | Maintains | Equal-Weight |
As of October 16, 2026, 46 Wall Street analysts cover MRVL: 42 rate it a buy or strong buy, 4 a hold and 0 a sell or strong sell. Their 12-month price targets range from $210.00 to $450.00, with a median of $350.00, 53.7% above the price of $227.77.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
MRVL trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
MRVL moves about 3.6% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much MRVL tends to move, against the market and on its own.
The long record
MRVL's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 3.64% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 61.8%, from December 2021 to January 2023, regained by November 2024.Most 1-year holds ended higher ›
76% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $200,780, against $42,525 in the S&P 500 (SPY).
MRVL Drawdowns & Recovery
As of October 16, 2026, MRVL's worst peak-to-trough fall over the last 10 years with dividends reinvested was -61.8% (December 2021 to January 2023); it regained that peak by November 2024, 22 months after the low, and 76% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into MRVL in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: MRVL beat the S&P 500 over this period: $200,780 against $42,525.
A $10,000 investment in MRVL in October 2016 would be worth about $200,780 today with dividends reinvested, compared with about $42,525 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to MRVL, and which have not.
Strongest month, May: an average of +12.28%, up in 8 of 10 years.
Weakest month, February: an average of -2.10%, up in 6 of 10 years.
This month, October: has averaged +0.69%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, MRVL's strongest calendar month has been May (average +12.28%, up in 8 of 10 years) and its weakest February (average -2.10%, up in 6 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in MRVL, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in MRVL today could grow to about $29,824 by 2036 in the base case, with a 90th-percentile outcome near $226,262 and a 10th-percentile outcome around $3,931. The simulation models price only; at today's 0.11% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
MRVL Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $353 for MRVL by 2030 in the base case, from $228 today (1.5x over 4 years). The 10th-percentile path ends near $97.89. These are outcomes of a Monte Carlo simulation run on MRVL's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $134 | $254 | $482 | |
| 2028 | $115 | $283 | $701 | |
| 2029 | $104 | $316 | $959 | |
| 2030 | $97.89 | $353 | $1,270 | |
| 2031 | $93.86 | $393 | $1,648 |
Method: a lognormal simulation of MRVL's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. MRVL is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation.
Insider trading
What the people running the company have bought and sold.
MRVL insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $2.1M on the open market and sold $48.7M.
As of October 16, 2026, MRVL insiders reported 34 open-market sales worth $48.7M and 4 open-market purchases worth $2.1M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Sell | 7.5K | $1.7M |
| Sep 15, 2026 | Daniel James Durn
Chief Financial Officer
|
Grant | 6.5K | - |
| Sep 1, 2026 | Christopher R Koopmans
President
|
Sell | 10.0K | $2.0M |
| Aug 17, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Sell | 7.5K | $1.8M |
| Aug 14, 2026 | Justin Scarpulla
Officer
|
Grant | 3.2K | - |
| Aug 3, 2026 | Christopher R Koopmans
President
|
Sell | 10.0K | $1.8M |
| Jul 16, 2026 | Sandeep Bharathi
Officer
|
Sell | 9.0K | $1.8M |
| Jul 15, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Sell | 7.5K | $1.6M |
| Jul 15, 2026 | Sandeep Bharathi
Officer
|
Grant | 22.4K | - |
| Jul 15, 2026 | Mark John Casper
Officer
|
Grant | 4.1K | - |
| Jul 15, 2026 | Christopher R Koopmans
President
|
Grant | 21.5K | - |
| Jul 15, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Grant | 21.5K | - |
| Jul 15, 2026 | Justin Scarpulla
Officer
|
Grant | 510 | - |
| Jul 1, 2026 | Christopher R Koopmans
President
|
Sell | 10.0K | $2.8M |
| Jun 25, 2026 | Rajiv Ramaswami
Director
|
Grant | 3.1K | - |
| Jun 23, 2026 | Daniel James Durn
Chief Financial Officer
|
Sell | 2.3K | $632.3K |
| Jun 17, 2026 | Rebecca Wickhem House
Director
|
Grant | 750 | - |
| Jun 16, 2026 | Sandeep Bharathi
Officer
|
Sell | 2.2K | $667.4K |
| Jun 15, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Sell | 7.5K | $2.2M |
| Jun 15, 2026 | Sandeep Bharathi
Officer
|
Grant | 4.7K | - |
| Jun 15, 2026 | Mark John Casper
Officer
|
Grant | 1.0K | - |
| Jun 12, 2026 | Bradley W Buss
Director
|
Grant | 3.9K | - |
| Jun 12, 2026 | Rebecca Wickhem House
Director
|
Grant | 3.9K | - |
| Jun 12, 2026 | Marachel Knight
Director
|
Grant | 3.9K | - |
| Jun 12, 2026 | Richard P Wallace
Director
|
Grant | 3.9K | - |
| Jun 10, 2026 | Daniel James Durn
Director
|
Grant | 3.9K | - |
| May 20, 2026 | Christopher R Koopmans
President
|
Grant | 18.7K | - |
| May 20, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Grant | 117.7K | - |
| May 15, 2026 | Willem A Meintjes
Chief Financial Officer
|
Sell | 4.0K | $701.0K |
| May 15, 2026 | Christopher R Koopmans
President
|
Grant | 56.2K | - |
| May 13, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Sell | 7.5K | $1.3M |
| May 1, 2026 | Christopher R Koopmans
President
|
Sell | 10.0K | $1.6M |
| Apr 17, 2026 | Mark John Casper
Officer
|
Sell | 10.0K | $1.4M |
| Apr 16, 2026 | Sandeep Bharathi
Officer
|
Sell | 66.9K | $8.7M |
| Apr 15, 2026 | Willem A Meintjes
Chief Financial Officer
|
Sell | 30.0K | $4.0M |
| Apr 15, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Sell | 7.5K | $1.0M |
| Apr 15, 2026 | Sandeep Bharathi
Officer
|
Grant | 141.3K | - |
| Apr 15, 2026 | Mark John Casper
Officer
|
Grant | 83.0K | - |
| Apr 15, 2026 | Christopher R Koopmans
President
|
Grant | 170.0K | - |
| Apr 15, 2026 | Willem A Meintjes
Chief Financial Officer
|
Grant | 131.0K | - |
| Apr 15, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Grant | 938.3K | - |
| Apr 6, 2026 | Mark John Casper
Officer
|
Sell | 6.9K | $755.2K |
| Apr 2, 2026 | Mark John Casper
Officer
|
Sell | 17.9K | $1.9M |
| Mar 26, 2026 | Sandeep Bharathi
Officer
|
Sell | 44.4K | $4.4M |
| Mar 26, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Sell | 30.0K | $3.0M |
| Feb 2, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Grant | 144.7K | - |
| Jan 15, 2026 | Sandeep Bharathi
Officer
|
Grant | 11.5K | - |
| Jan 15, 2026 | Mark John Casper
Officer
|
Grant | 5.1K | - |
| Jan 15, 2026 | Christopher R Koopmans
Chief Executive Officer
|
Grant | 11.4K | - |
| Jan 15, 2026 | Willem A Meintjes
Chief Financial Officer
|
Grant | 59.7K | - |
| Jan 15, 2026 | Matthew Joseph Murphy
Chief Executive Officer
|
Grant | 26.4K | - |
| Jan 5, 2026 | Mark John Casper
Officer
|
Sell | 5.0K | $465.4K |
| Dec 15, 2025 | Sandeep Bharathi
Officer
|
Grant | 59.7K | - |
| Dec 15, 2025 | Mark John Casper
Officer
|
Grant | 30.5K | - |
| Dec 15, 2025 | Christopher R Koopmans
President
|
Grant | 55.0K | - |
| Dec 15, 2025 | Willem A Meintjes
Chief Financial Officer
|
Grant | 17.1K | - |
| Dec 5, 2025 | Mark John Casper
Officer
|
Sell | 1.3K | $126.6K |
| Nov 14, 2025 | Mark John Casper
Officer
|
Grant | 2.5K | - |
| Oct 17, 2025 | Matthew Joseph Murphy
Chief Executive Officer
|
Grant | 22.7K | - |
| Oct 15, 2025 | Sandeep Bharathi
Officer
|
Grant | 11.5K | - |
| Oct 15, 2025 | Mark John Casper
Officer
|
Grant | 6.9K | - |
| Oct 15, 2025 | Christopher R Koopmans
President
|
Grant | 11.4K | - |
| Oct 15, 2025 | Willem A Meintjes
Chief Financial Officer
|
Grant | 12.4K | - |
| Oct 15, 2025 | Matthew Joseph Murphy
Chief Executive Officer
|
Grant | 20.9K | - |
| Sep 25, 2025 | Sandeep Bharathi
Officer
|
Buy | 3.4K | $265.3K |
| Sep 25, 2025 | Christopher R Koopmans
President
|
Buy | 6.8K | $530.6K |
| Sep 25, 2025 | Willem A Meintjes
Chief Financial Officer
|
Buy | 3.4K | $265.3K |
| Sep 25, 2025 | Matthew Joseph Murphy
Officer and Director
|
Buy | 13.6K | $1.0M |
| Jul 18, 2025 | Mark John Casper
Officer
|
Sell | 3.0K | $217.1K |
| Jul 15, 2025 | Sandeep Bharathi
Officer
|
Grant | 11.5K | - |
| Jul 15, 2025 | Mark John Casper
Officer
|
Grant | 6.9K | - |
| Jul 15, 2025 | Christopher R Koopmans
President
|
Grant | 11.4K | - |
| Jul 15, 2025 | Willem A Meintjes
Chief Financial Officer
|
Grant | 12.4K | - |
| Jul 15, 2025 | Matthew Joseph Murphy
Chief Executive Officer
|
Grant | 20.9K | - |
| Jun 16, 2025 | Willem A Meintjes
Chief Financial Officer
|
Sell | 1.5K | $102.8K |
| Jun 16, 2025 | Panteha Dixon
Officer
|
Sell | 1.3K | $87.9K |
| Jun 13, 2025 | Tudor Brown
Director
|
Grant | 3.3K | - |
| Jun 13, 2025 | Bradley W Buss
Director
|
Grant | 3.3K | - |
| Jun 13, 2025 | Daniel J Durn
Director
|
Grant | 3.3K | - |
| Jun 13, 2025 | Marachel Knight
Director
|
Grant | 3.3K | - |
| Jun 13, 2025 | Michael G Strachan
Director
|
Grant | 7.6K | - |
| Jun 13, 2025 | Robert E Switz
Director
|
Grant | 3.3K | - |
| Jun 13, 2025 | Richard P Wallace
Director
|
Grant | 3.3K | - |
| May 19, 2025 | Mark John Casper
Officer
|
Sell | 626 | $38.2K |
| May 15, 2025 | Christopher R Koopmans
Chief Operating Officer
|
Sell | 6.0K | $390.6K |
| May 15, 2025 | Willem A Meintjes
Chief Financial Officer
|
Sell | 1.5K | $97.1K |
| May 15, 2025 | Panteha Dixon
Officer
|
Sell | 1.2K | $80.5K |
| May 15, 2025 | Mark John Casper
Officer
|
Grant | 2.5K | - |
| May 12, 2025 | Christopher R Koopmans
Chief Operating Officer
|
Sell | 6.0K | $390.0K |
| May 12, 2025 | Panteha Dixon
Officer
|
Sell | 1.3K | $83.6K |
| May 1, 2025 | Willem A Meintjes
Chief Financial Officer
|
Sell | 1.5K | $90.0K |
| May 1, 2025 | Michael G Strachan
Director
|
Grant | 4.3K | - |
| Apr 23, 2025 | Mark John Casper
Officer
|
Sell | 12.5K | $685.3K |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 16, 2026.